Date Filed | Type | Description |
08/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/18/2023 |
4
| Dockendorff Charles J (Director) has filed a Form 4 on BOSTON SCIENTIFIC CORP
Txns:
| Sold 17,079 shares
@ $50.7425, valued at
$866.6k
|
|
08/08/2023 |
4
| Dockendorff Charles J (Director) has filed a Form 4 on HAEMONETICS CORP
Txns:
| Granted 2,226 shares
@ $0 |
|
05/05/2023 |
4
| Dockendorff Charles J (Director) has filed a Form 4 on BOSTON SCIENTIFIC CORP
Txns:
| Granted 3,946 shares
@ $0 Gifted 8,201 shares
@ $0 |
|
03/21/2023 |
4
| Dockendorff Charles J (Director) has filed a Form 4 on Keysight Technologies, Inc.
Txns:
| Granted 1,543 shares
@ $0 |
|
03/13/2023 |
4
| Dockendorff Charles J (Director) has filed a Form 4 on HOLOGIC INC
Txns:
| Granted 1,465 shares
@ $0 Granted 4,210 options to buy
@ $78.49, valued at
$330.4k
|
|
02/09/2023 |
4
| Dockendorff Charles J (Director) has filed a Form 4 on HOLOGIC INC
Txns:
| Gifted 1,336 shares
@ $0 |
|
01/10/2023 |
4
| Dockendorff Charles J (Director) has filed a Form 4 on Keysight Technologies, Inc.
Txns:
| Gifted 2,844 shares
@ $0 |
|
12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/22/2022 |
4
| Dockendorff Charles J (Director) has filed a Form 4 on Keysight Technologies, Inc.
Txns:
| Granted 1,626 shares
@ $0 |
|
03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/07/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
08/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/11/2020 |
4
| Dockendorff Charles J (Director) has filed a Form 4 on BOSTON SCIENTIFIC CORP
Txns:
| Granted 5,000 shares
@ $0 |
|
03/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/26/2019 |
4
| Dockendorff Charles J (Director) has filed a Form 4 on HAEMONETICS CORP
Txns:
| Granted 1,460 shares
@ $0 |
|
05/13/2019 |
4
| Dockendorff Charles J (Director) has filed a Form 4 on BOSTON SCIENTIFIC CORP
Txns:
| Granted 4,990 shares
@ $0 |
|
03/25/2019 |
4
| Dockendorff Charles J (Director) has filed a Form 4 on Keysight Technologies, Inc.
Txns:
| Granted 2,351 shares
@ $0 |
|
03/11/2019 |
4
| Dockendorff Charles J (Director) has filed a Form 4 on HOLOGIC INC
Txns:
| Granted 2,136 shares
@ $0 Granted 6,523 options to buy
@ $46.81, valued at
$305.3k
|
|
07/30/2018 |
4
| Dockendorff Charles J (Director) has filed a Form 4 on HAEMONETICS CORP
Txns:
| Granted 1,696 shares
@ $0 |
|
05/11/2018 |
4
| Dockendorff Charles J (Director) has filed a Form 4 on BOSTON SCIENTIFIC CORP
Txns:
| Granted 6,109 shares
@ $0 |
|
03/26/2018 |
4
| Dockendorff Charles J (Director) has filed a Form 4 on Keysight Technologies, Inc.
Txns:
| Granted 1,949 shares
@ $0 Granted 780 shares
@ $0 Granted 3,897 shares
@ $0 |
|
03/16/2018 |
4
| Dockendorff Charles J (Director) has filed a Form 4 on HOLOGIC INC
Txns:
| Granted 2,406 shares
@ $0 Bought 13,000 shares
@ $38.8, valued at
$504.4k
Granted 7,551 options to buy
@ $38.44, valued at
$290.3k
|
|
07/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/13/2017 |
4
| Dockendorff Charles J (Director) has filed a Form 4 on Keysight Technologies, Inc.
Txns:
| Bought 13,210 shares
@ $37.81, valued at
$499.5k
|
|
05/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|